Outlook Therapeutics (OTLK) Non-Current Assets (2015 - 2026)
Outlook Therapeutics (OTLK) reported Non-Current Assets of $3.02 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 132.9% from $1.3 million a year earlier and up 205.4% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics posted Non-Current Assets of $1.2 million, down 15.1% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
- By fiscal year, Non-Current Assets came in at $1.41 million in FY2024 (+6.5%), $1.32 million in FY2023 (+31.2%), $1.01 million in FY2022 (-22.7%) and $1.3 million in FY2021 (-27.1%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Non-Current Assets since fiscal Q2 2020.
- Year over year, Non-Current Assets gained in four of the last eight quarters, with growth averaging 9.4%.
- The high point for year-over-year Non-Current Assets in five years was fiscal Q3 2026 (growth of 132.9%); the low point was fiscal Q4 2021 (a decline of 27.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $987,695 (Q2 2026), $1.07 million (Q1 2026) and $1.2 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | 3.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.02 Mn |
| Mar 31, 2026 | 987,695.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 971,901.00 |
| Dec 31, 2022 | 1.01 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.30 Mn |
API Access
Outlook Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();